Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Rheumatology
Published in: Pediatric Rheumatology 1/2013

Open Access 01-11-2013 | Meeting abstract

P03-024 – Early onset IBD treated by tocilizumab

Authors: R Helbling, A Nyddeger, F Angelini, A Von Scheven Gete, M Hofer

Published in: Pediatric Rheumatology | Special Issue 1/2013

Login to get access

Excerpt

Inflammatory bowel diseases (IBD) normally manifest in adolescent and young adults; nevertheless, in about 1% of the cases, disease onset occurs before the 1st year of age. The clinical picture is often characterized by an indeterminate colitis whose clinical remission is difficult to achieve. Current treatment for IBD consists of either immunosuppressant or biological (Infliximab, Adalimumab) agents. …
Literature
1.
Kotlarz D: Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology. 2012, 143 (2): 347-55.CrossRefPubMed
2.
Smolen JS: Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. Ann Rheum Dis. 2013, 72 (4): 482-92.PubMedCentralCrossRefPubMed
Metadata
Title
P03-024 – Early onset IBD treated by tocilizumab
Authors
R Helbling
A Nyddeger
F Angelini
A Von Scheven Gete
M Hofer
Publication date
01-11-2013
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue Special Issue 1/2013
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-11-S1-A222

Other articles of this Special Issue 1/2013

Pediatric Rheumatology 1/2013 Go to the issue

Meeting abstract

PW03-029 – Risk factors for AA-type amyloidosis in Germany

Meeting abstract

P02-015 - A novel MVK mutation in a child with AA amyloid

Meeting abstract

PW01-008 – The inflammasome and secretory pathways in FMF

Meeting abstract

PW03-005 - NLRP3-Q705K monocytes do not produce more IL-1B

Meeting abstract

OR10-002 - A novel TNFR1 transcript of TRAPS gene

Meeting abstract

OR2-002 – The risk of FMF in MEFV heterozygotes